GPs from private practice (n= 351) | GPs from polyclinic (n= 76) | P-value | |
---|---|---|---|
What percentage of AURI are caused by viruses? n (%) | |||
<20% | 14 (5.0) | 0 (0) | |
20–39% | 21 (6.0) | 1 (1.3) | |
40–59% | 107 (30.5) | 18 (23.7) | |
60–79% | 4 (1.1) | 2 (2.6) | |
>80% | 205 (58.4) | 55 (72.4) | 0.03 |
There is a scoring system to assess the likelihood of streptococcal infection in pharyngitis/tonsillitis (modified Centor score), n (%) | 163 (46.4) | 60 (78.9) | <0.01 |
Purulence of nasal discharge/sputum (yellow/green) indicates increased likelihood of bacterial infection, n (%) | 197 (56.1) | 20 (26.3) | <0.01 |
I think empirical antibiotics are indicated in the following acute respiratory infections, n (%): | |||
Acute otitis media | 315 (89.7) | 62 (81.6) | 0.05 |
Rhinitis | 12 (3.4) | 1 (1.3) | 0.48 |
Acute sinusitis | 281 (80.1) | 53 (69.7) | 0.07 |
Laryngitis/pharyngitis | 92 (26.2) | 11 (14.5) | 0.04 |
Tonsillitis | 332 (94.6) | 58 (76.3) | <0.01 |
Tracheobronchitis | 199 (56.7) | 29 (38.2) | <0.01 |
What is the proportion of patients with AURI to whom you prescribe antibiotics? n (%) | |||
Low prescriber (<20%) | 139 (39.6) | 61 (80.3) | <0.01 |
What is the most serious problem you foresee in overprescription of antibiotics? n (%) | |||
Drug–drug interaction | 0 (0) | 1 (1.3) | |
Increased antibiotic resistance | 319 (90.9) | 71 (93.4) | |
Increased costs | 2 (0.6) | 1 (1.3) | |
Possible side effects/allergies/adverse events | 25 (7.1) | 3 (3.9) | |
Other | 5 (1.4) | 0 (0) | 0.18 |
AURI = acute upper respiratory tract infections.